CYBB and atrial fibrillation: Collectively, both genetic and pharmacologic inhibition of NOX2 in obese mice and PA-treated hiPSC-aCMs abrogates ion channel and structural remodeling and prevents obesity-mediated AF in part by transcriptional regulation of PITX2.